Immunotherapy Segment Bolsters Skin Cancer Treatment Market Growth

According to our new research study on "Skin Cancer Treatment Market Forecast to 2031 - Global Analysis - by Type, Therapy, and End User," the market size is expected to grow from US$ 11.79 billion in 2024 to US$ 19.53 billion by 2031; the market is expected to register a CAGR of 7.57% during 2025-2031. The Skin Cancer Treatment Market report emphasizes the trends prevalent in the global market, along with drivers and deterrents affecting its growth.

The rising product approvals and expanding product pipeline as an contribute to the growing Skin Cancer Treatment Market size. However, the high treatment costs hampers the growth of the market. Further, rising Shift Toward Precision and Patient-Centered Therapies are expected to bring new Skin Cancer Treatment Market trends in the coming years.

Increasing Incidences of Skin Cancers Bolsters Skin Cancer Treatment Market Growth

According to the National Cancer Institute, melanoma incidence has increased by 1.2% annually over the past decade. In the same period, the incidence of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) has risen dramatically, by 145% and 263%, respectively. This rise is linked to prolonged UV exposure and insufficient sun protection, particularly among older adults who have accumulated UV damage over time.

Furthermore, Cancer Research UK reports approximately a 57% increase in melanoma cases among individuals over 80 and a 7% rise among young adults aged 25 to 49 in 2024.

The American Cancer Society estimated around 212,200 new melanoma cases in the US in 2025, with 107,240 classified as in situ and 104,960 as invasive cases, making melanoma the fifth most common cancer. Additionally, government campaigns focused on early detection, run by organizations such as Health Canada and the Public Health Agency of Canada, have led to an increase in diagnoses by promoting regular skin checks. This, in turn, has increased the demand for topical therapies and immunotherapies.

Thus, the increasing global prevalence of skin cancer fuels the skin cancer treatment market growth.

The Skin Cancer Treatment Market analysis has been carried out by considering the following segments: material, form, and end user, and geography. Based on type, the market is segmented into Melanoma and Nonmelanoma. The nonmelanoma segment held the largest skin cancer treatment market share in 2024 and is expected to register the highest CAGR during 2025-2031.

By therapy, the skin cancer treatment market is classified into immunotherapy, targeted therapy, chemotherapy, radiation therapy, and others. The immunotherapy segment held a larger share of the skin cancer treatment market in 2024 and is expected to register a higher CAGR during 2025-2031.

In terms of end users, the skin cancer treatment market is segmented into dermatology clinics, hospitals, diagnostic centers, and others. The hospitals segment dominated the skin cancer treatment market in 2024 and is anticipated to register the highest CAGR during 2025-2031. According to the Centers for Disease Control and Prevention (CDC), in 2021, the United States reported approximately 83,000 new cases of melanoma. In addition, nonmelanoma skin cancers affected over 3 million people annually. Dermatology clinics play a crucial role in delivering treatments such as Mohs surgery, cryotherapy, and topical therapies, as well as providing preventive education. For example, in 2024, the Skin Cancer Foundation highlighted a California-based dermatology clinic's initiative to offer free skin cancer screenings. This initiative successfully identified early-stage melanomas in 15% of participants, emphasizing the clinic's importance in early intervention.

Patients often prefer dermatology clinics due to their specialized expertise and accessibility compared to hospitals, particularly for outpatient procedures. The American Academy of Dermatology notes that over 70% of skin cancer patients seek initial treatment at dermatology clinics, drawn by shorter wait times and specialized care.

These clinics also cater to high-risk groups, such as organ transplant recipients, who require regular screenings due to the elevated skin cancer risks associated with immunosuppressive drugs. A 2023 report from the National Cancer Institute indicated that transplant patients are up to 100 times more likely to develop skin cancer, which drives the demand for monitoring in clinic settings.

Skin Cancer Treatment Market Share, by End User, 2024 (%)

Source: The Insight Partners Analysis

The geographic scope of the Skin Cancer Treatment Market report includes the assessment of the market performance in North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. North America is expected to dominate the market in 2024. The market for skin cancer treatment is rapidly evolving due to rising incidence rates, increased public awareness, and greater government involvement in cancer prevention and treatment. According to the Centers for Disease Control and Prevention (CDC), skin cancer is the most common form of cancer in the United States, with over 5 million cases treated each year. This treatment costs the healthcare system an estimated US$ 8.1 billion annually. The US Food and Drug Administration (FDA) has approved several new therapies, including immune checkpoint inhibitors such as pembrolizumab and nivolumab, which are reshaping treatment strategies for advanced melanoma. In 2024, the FDA also approved lifileucel, a tumor-infiltrating lymphocyte (TIL) therapy, for patients with metastatic melanoma who do not respond to existing treatments. This approval marks a significant advancement in personalized, cell-based cancer therapies in North America.

Canada has also seen a rising incidence of skin cancer. According to Melanoma Canada, approximately 11,300 people were diagnosed with melanoma in 2024. The Public Health Agency of Canada has prioritized sun safety campaigns and has improved access to dermatological care, particularly in remote and Indigenous communities through teledermatology and mobile screening programs. Provincial health systems are increasingly covering advanced treatments like immunotherapy for melanoma under public healthcare plans, thereby improving access for diverse populations.

Public initiatives such as the Surgeon General's Call to Action to Prevent Skin Cancer and school-based sun safety education programs are also driving behavioral change. As a result, the combination of advanced therapeutics, a high disease burden, and strong government policy, along with regulatory support and preventive health strategies, is expected to drive growth in the skin cancer treatment market in the coming years.

Contact Us
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com